Daniel Gerlach - Discovery Res, Boehringer Ingelheim RCV GmbH & Co KG

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 67 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 3143: The ADC payload PNU-159682 is highly active in a wide range of cancer indications by inducing DNA damage and cell death via a distinct mode of action

Monika Kaiser, Ulrike Fiedler,Daniel Gerlach,Norbert Kraut, Lukas Bammert

Cancer Researchno. 6_Supplement (2024): 3143-3143

引用0浏览0引用

Development and characterisation of KRASmulti inhibitors for the treatment of KRAS mutant pancreatic ductal adenocarcinoma

Antonio Tedeschi,Otmar Schaaf,Michael Gmachl,Lorenz Herdeis, Francesca Rocchetti,Johannes Popow,Fiorella Schischlik,Daniel Gerlach,Jesse Lipp, Joachim Broker,Andreas Mantoulidis, Chris Smethurst,

CANCER RESEARCHno. 2 (2024)

引用0浏览0引用

SOS1 inhibition enhances the efficacy of and delays resistance to G12C inhibitors in lung adenocarcinoma

Brianna R Daley,Nancy E Sealover,Erin Sheffels, Jacob M Hughes,Daniel Gerlach,Marco H Hofmann,Kaja Kostyrko, Barbara Mair, Amanda Linke, Zaria Beckley,Andrew Frank,Clifton Dalgard,

bioRxiv : the preprint server for biology (2023)

引用0浏览0WOS引用

SOS1 inhibition is an effective therapeutic strategy in SOS1-mutant cancer

Matthew J. Sale, Neal Mukherjee, Regina Ruzicka,Robin Jacob,Christoph Albrecht, Teresa Zanin, Tom Madensky,Kaja Kostyrko, Robyn L. Schenk,Anke Baum,Daniel Gerlach,Marco H. Hofmann,

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Molecular basis of GDF15 induction and suppression by drugs in cardiomyocytes and cancer cells toward precision medicine

Lisa-Maria Winter, Diana Reinhardt, Ariane Schatter, Vivien Tissen, Heike Wiora,Daniel Gerlach,Ulrike Tontsch-Grunt,Florian Colbatzky,Birgit Stierstorfer, Seong-Wook Yun

Scientific Reportsno. 1 (2023): 1-13

引用0浏览0WOSNATURE引用

Abstract 1715: SOS1 inhibition is an effective therapeutic strategy in SOS1-mutant cancer

Matthew J. Sale, Nupur Mukherjee, Regina Ruzicka, Rolf G. Jacob,Christoph Albrecht, Teresa Zanin, Tom Madensky,Kaja Kostyrko, Robyn L Schenk,Anke Baum,Daniel Gerlach,Marco H. Hofmann,

Cancer Researchno. 7_Supplement (2023): 1715-1715

引用0浏览0引用

Combined KRASG12C and SOS1 inhibition enhances and extends the anti-tumor response in KRASG12C-driven cancers by addressing intrinsic and acquired resistance

Venu Thatikonda,Hengyu Lu,Sabine Jurado,Kaja Kostyrko,Christopher A Bristow, Karin Bosch,Ningping Feng,Sisi Gao,Daniel Gerlach,Michael Gmachl,Simone Lieb, Astrid Jeschko,

bioRxiv : the preprint server for biology (2023)

引用4浏览0WOS引用

Combined KRAS^G12Cand SOS1 inhibition enhances and extends the anti-tumor response in KRAS^G12C-driven cancers by addressing intrinsic and acquired resistance

Venu Thatikonda,Hengyu Lu,Sabine Jurado,Kaja Kostyrko, Christopher A. Bristow, Karin Bosch,Ningping Feng,Shuwei Gao,Daniel Gerlach, Michael Gerlach,Simone Lieb, Astrid Jeschko,

bioRxiv (Cold Spring Harbor Laboratory) (2023)

引用0浏览0引用

Abstract LB079: Pancreatic clonal replica tumors display functional heterogeneity in response to KRAS pharmacological inhibition and reveal unique epigenetic vulnerabilities to overcome resistance

Hengyu Lyu,Rosalba Minelli,Charles E. Deckard,Sahil Seth,Justin Huang,Hong Jiang,Michael D. Peoples, Meggie Lam,Christopher A. Bristow,Daniel Gerlach,Ulrike Tontsch-Grunt,Chieh-Yuan Li,

Cancer Researchno. 12_Supplement (2022): LB079-LB079

引用0浏览0引用

Abstract 3623: Targetable cofactor landscape of transcription factors in human cancers

Venu Thatikonda,Jesse Lipp,Andreas Schlattl,Daniel Gerlach,Alexandra Popa

Cancer Researchno. 12_Supplement (2022): 3623-3623

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn